University of Alabama Birmingham
Regulation of p27KIP1 by TRIP6 and its implications in cancer progression
Abstract
dc:description.abstractTRIP6 is a focal adhesion molecule that functions as an adaptor protein to mediate diverse cellular functions, including motility and antiapoptotic signaling, through a wide variety of protein-protein interactions. We were able to characterize a novel interaction between TRIP6 and p27KIP1, a CDK inhibitor which can both suppress and promote tumorigenesis, depending on its regulation. TRIP6 expression specifically promotes the AKT-mediated phosphorylation of p27KIP1 at T157, which leads to its cytosolic retention, and accelerates the protein turnover rate of p27KIP1. We also found that phosphorylation of T157 by itself promotes cell motility and can be linked to the formation of motility-associated cytoskeletal structures, including podosome-like actin bundles. Finally, we were able to demonstrate that TRIP6 knockdown inhibits tumorigenesis of both ovarian cancer and glioblastoma xenografts in vivo and that its overexpression correlates to poor outcome in human gliomas. Because of these findings, TRIP6 may be useful as a novel prognostic biomarker for the assessment of all human gliomas, as well as a target for future therapeutic interventions.
Degree
thesis:*- Level thesis:degree_level
- Dissertation
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Lin, Victor T G
- Contributors dc:contributor
-
- Fang-Tsyr Lin
- Susan L Bellis
- Etty N Benveniste
- Danny R Welch
Subjects
dc:subject × 7Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.uab.edu/etd-collection/2294